Tokyo, December 16, 2021 - NEC Corporation (NEC; TSE: 6701) announced today the development of an AI technology with Ono Pharmaceutical Co., Ltd. that detects particles in glass bottles. This technology uses AI to learn the difference in movements between bubbles and particles in liquid for injections within glass bottles. The technology is even able to detect micro-particles that have been difficult to identify until now with high accuracy. Both companies aim to commercialize the technology in the 2022 fiscal year.

In the process of inspecting liquids for injections that are contained in glass bottles, such as anti-cancer drugs and vaccines, it is common for bottles suspected of containing particles to be automatically removed by inspection equipment, and for a secondary visual inspection to take place by inspectors. Initially, an image-based inspection is performed on all glass bottles. However, normal bottles are often recognized as defective and eliminated. This is due to bubbles being recognized as particles. In addition, advanced skill and know-how are required for inspectors to perform secondary visual inspections, inspection quality often varies, and securing inspectors at the time of production is a challenge.

NEC has partnered with Ono Pharmaceutical to reduce the number of visual inspections by applying this new AI technology to automated inspections, aiming to realize rapid processes that feature uniform inspection quality and help to support the expansion of production.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

NEC Corporation published this content on 16 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 December 2021 04:29:08 UTC.